Clinical trials
Completed Dyslipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
790 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 5 |
| 2002 | 9 |
| 2003 | 21 |
| 2004 | 26 |
| 2005 | 38 |
| 2006 | 53 |
| 2007 | 42 |
| 2008 | 48 |
| 2009 | 29 |
| 2010 | 34 |
| 2011 | 42 |
| 2012 | 34 |
| 2013 | 28 |
| 2014 | 44 |
| 2015 | 28 |
| 2016 | 39 |
| 2017 | 33 |
| 2018 | 32 |
| 2019 | 35 |
| 2020 | 19 |
| 2021 | 36 |
| 2022 | 24 |
| 2023 | 27 |
| 2024 | 22 |
| 2025 | 18 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 790 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 51 |
| Chong Kun Dang Pharmaceutical | 37 |
| Takeda | 36 |
| Merck Sharp & Dohme LLC | 16 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 15 |
| Abbott | 11 |
| Pfizer | 11 |
| UCSF Benioff Children's Hospital Oakland | 10 |
| Eli Lilly and Company | 9 |
| Kowa Research Europe | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 790 |
| Hypertension | 153 |
| Diabetes Mellitus | 112 |
| Hypercholesterolemia | 110 |
| Diabetes Mellitus, Type 2 | 102 |
| Obesity | 100 |
| Cardiovascular Diseases | 70 |
| Hyperlipidemias | 69 |
| Metabolic Syndrome | 61 |
| Insulin Resistance | 48 |
Trials
Showing 1 to 25 of 790. Each trial links to its page on Pharma Observatory.
690 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.